FDA Issues: Review & Approval of New Drugs & Other Regulatory Issues
- Guidance for Industry: Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment (PDF) (June 2013)
From U.S. Food and Drug Administration
- New Guidance for Industry: Developing Antiretroviral Drugs for Treatment of HIV-1 (June 10, 2013)
From U.S. Food and Drug Administration
On TheBodyPRO.com
- FDA Announces Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research (May 14, 2013)
From U.S. Food and Drug Administration
New HIV Drug Dolutegravir Could Soon Be Approved by FDA (February 28, 2013)
From TheBodyPRO.com
What's a Fulyzaq? I Thought You'd Never Ask (January 3, 2013)
From Journal Watch
On TheBodyPRO.com
- FDA Approval of Generic ARVs (November/December 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Food and Drug Administration Urged to Speed Approval of Drugs (September 26, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Approval of Generic ARVs (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- How HIV Drugs Get Approved (August 9, 2012)
To read PDF, click here.
From AIDS InfoNet
- More Than 150 Antiretroviral Drugs Available Through PEPFAR for Worldwide HIV/AIDS Relief (July 23, 2012)
From U.S. Food and Drug Administration
VIEW ALL ARTICLES
|
Advertisement
|